Annual Report for the financial year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthy Investments Limited filed its 43rd Annual Report for FY 2024-25. Total revenue fell about 42% to ₹2.086 Million from ₹3.623 Million last year, as the company earns mainly from dividends and investment dealing. The company swung to a loss after tax of ₹5.876 Million compared to a profit of ₹1.509 Million in the previous year, driven by a large deferred tax charge of ₹6.279 Million. No dividend has been recommended and no amount has been transferred to reserves. The board noted no adverse audit observations, and a new secretarial auditor (M/s B S S & Associates) is being proposed for a 5-year term starting April 2025.
Shareholders face a weak year with both revenue contraction and a return to losses, along with no dividend. The stock may see negative sentiment given the sharp drop in income and swing to negative PAT, though the company remains debt-light with no subsidiaries and surplus reserves of ₹75.8 Million carried forward.